Price $70.85 |
Market Cap
4.12B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
145.8
|
P/B
4.12
|
P/S
3.97
|
Dividend %
-
|
|
P/CF
207.0
|
P/FCF
30.3
|
Op. Cash Flow
168.5K
|
FCF
2.4
|
|
Op. Margin
3.80%
|
Net Margin
2.70%
|
ROE
2.90%
|
ROI
0.10%
|
|
ROA
1.70%
|
EPS Growth
194.10%
|
Current Ratio
2.3
|
Debt/Equity
35.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $60.33 | - | 3.00% | 146.93B | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.71 | - | - | 709M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $23.96 | - | - | 1.1B | Strong Buy |
| Inogen Inc (INGN) | $46.75 | - | - | 1.36B | Strong Buy |
| Sensus Healthcare Inc (SRTS) | $3.54 | - | - | 60.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
